CardioMEMS-Guided CAR T Cell Therapy for Lymphoma in a Patient With Anthracycline-Induced Cardiomyopathy

CardioMEMS-Guided CAR T Cell Therapy for Lymphoma in a Patient With Anthracycline-Induced Cardiomyopathy

Bibliographic Details
Main Authors:	Anthony J. Kanelidis, MD, Jayant Raikhelkar, MD, Gene Kim, MD, Gabriel Sayer, MD, Michael R. Bishop, MD, Tamar S. Polonsky, MD, MSCI, Nir Uriel, MD, MSc
Format:	Article
Language:	English
Published:	Elsevier 2020-09-01
Series:	JACC. CardioOncology
Subjects:	anthracycline cardiomyopathy heart failure immunotherapy lymphoma
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666087320301526

Similar Items

Anthracycline cardiomyopathy
by: Vasiliy Nefedovich Anokhin, et al.
Published: (2011-10-01)

Electrocardiograms for cardiomyopathy risk stratification in children with anthracycline exposure
by: Lajja Desai, et al.
Published: (2019-08-01)

Anthracycline Cardiotoxicity
by: Umberto Campia, MD, MSc, et al.
Published: (2020-06-01)

Development of a Cardio-Oncology Program in a Community Hospital
by: Deborah W. Sundlöf, DO, et al.
Published: (2019-12-01)

Cardiomyopathy in a dog with multicentric lymphoma following treatment with several anthracyclines
by: Michihito Tagawa, et al.
Published: (2021-01-01)

Endovascular retrieval of a CardioMEMS heart failure system
by: Arun Reghunathan, MD, et al.
Published: (2018-04-01)

The cardiovascular system in patients with anthracycline cardiomiopathy
by: Alexandr T. Teplyakov, et al.
Published: (2017-10-01)

Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case series
by: Sarju Ganatra, et al.
Published: (2019-01-01)

CardioMEMS Implantation in Patient With a Systemic Right Ventricle
by: Daniel E. Clark, MD, MPH, et al.
Published: (2019-10-01)

Evaluating anthracycline cardiotoxicity associated single nucleotide polymorphisms in a paediatric cohort with early onset cardiomyopathy
by: Timothy N. McOwan, et al.
Published: (2020-05-01)

Anthracycline-Induced Cardiotoxicity
by: Jennifer E. Liu, MD
Published: (2020-03-01)

Correlation Between CardioMEMS and HeartLogic in Predicting Heart Failure Events
by: Semaan Kobrossi, MD, et al.
Published: (2020-11-01)

Pregnancy and Cardiomyopathy After Anthracyclines in Childhood
by: Kara Annette Thompson
Published: (2018-03-01)

Anthracycline induced cardiotoxicity: biomarkers and “Omics” technology in the era of patient specific care
by: Shayan Moazeni, et al.
Published: (2017-05-01)

iPSC-MSCs with High Intrinsic MIRO1 and Sensitivity to TNF-α Yield Efficacious Mitochondrial Transfer to Rescue Anthracycline-Induced Cardiomyopathy
by: Yuelin Zhang, et al.
Published: (2016-10-01)

Symptomatic Heart Failure in Acute Leukemia Patients Treated With Anthracyclines
by: Yu Kang, MD, PhD, et al.
Published: (2019-12-01)

Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity
by: Raquel Araujo-Gutierrez, et al.
Published: (2021-01-01)

State of Vegetative Homeostasis in Children with Anthracycline-Induced Cardiomyopathy
by: T.V. Shatynska, et al.
Published: (2014-03-01)

Early Detection and Prediction of Anthracycline-Induced Right Ventricular Cardiotoxicity by 3-Dimensional Echocardiography
by: Rui Zhao, MBBS, et al.
Published: (2020-03-01)

RISK FACTORS AND INCIDENCE OF MYOCARDIAL DAMAGE IN PATIENTS WITH HEMOBLASTOSIS RECEIVING ANTHRACYCLIN ANTIBIOTICS
by: N. T. Vatutin, et al.
Published: (2017-10-01)

Proceedings From the Global Cardio-Oncology Summit
by: Daniel J. Lenihan, MD, et al.
Published: (2019-12-01)

Diagnosis, Prevention, Treatment and Surveillance of Anthracycline-Induced Cardiovascular Toxicity in Pediatric Cancer Survivors
by: Valerie Curren, et al.
Published: (2021-01-01)

Rationale, Design, and Feasibility of a Prospective Multicenter Registry Study of Anthracycline-Induced Cardiotoxicity (AIC Registry)
by: Keiko Inoue, et al.
Published: (2021-03-01)

MODERN VIEW ON CARDIOTOXICITY OF CHEMOTHERAPEUTICS IN ONCOLOGY INCLUDING ANTHRACYCLINES
by: G. E. Gendlin, et al.
Published: (2017-03-01)

Analysis of Models of Doxorubicin-Induced Cardiomyopathy in Rats and Mice. A Modern View From the Perspective of the Pathophysiologist and the Clinician
by: Ekaterina Yu Podyacheva, et al.
Published: (2021-06-01)

Dexrazoxane in anthracycline cardiotoxicity
by: Abhijit S Nair
Published: (2017-01-01)

An update on the CardioMEMS pulmonary artery pressure sensor
by: Puvanalingam Ayyadurai, et al.
Published: (2019-02-01)

Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer
by: Ariane V.S. Macedo, MD, MSc, et al.
Published: (2019-09-01)

Computed Tomographic Angiography Assessment of Epicardial Coronary Vasoreactivity for Early Detection of Doxorubicin-Induced Cardiotoxicity
by: Attila Feher, MD, PhD, et al.
Published: (2020-06-01)

A Pilot Study of Matrix Metalloproteinases on the Model of Daunorubicin-induced Cardiomyopathy in Rabbits
by: Anna Potáčová, et al.
Published: (2007-01-01)

The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity
by: Lori M. Minasian, MD, et al.
Published: (2019-09-01)

Studies on heterocyclic compounds related to anthracyclines
by: Harper, Mark F.
Published: (1985)

The prognostic value of the NT-proBNP biomarkers and Fas ligand in assessing the risk of cardiotoxicity of anthracycline chemotherapy
by: A. T. Teplyakov, et al.
Published: (2019-03-01)

Hypertrophic Cardiomyopathy
by: Polakit Teekakirikul, MD, et al.
Published: (2021-09-01)

Saw-Tooth Cardiomyopathy
by: Julie Proukhnitzky, MD, et al.
Published: (2020-07-01)

Takotsubo Cardiomyopathy With Pheochromocytoma
by: Vikram Agarwal, MD, MPH
Published: (2019-08-01)

Approaches to the synthesis of xanthone analogs of the anthracycline class of anticancer agents
by: Mancini, Michael.
Published: (1985)

Outcomes in patients with anthracycline‐induced cardiomyopathy undergoing left ventricular assist devices implantation
by: Avirup Guha, et al.
Published: (2021-08-01)

Echocardiographic Changes after Treatment with Anthracyclines in Children
by: Hamid Amoozgar, et al.
Published: (2012-03-01)

Redox inactive ring C - aglycones of anthracyclines
by: Nicholson, J. R.
Published: (1988)